Cromos Pharma, where the patients are

Awards & Advancement

GSK names inaugural winners in competition for academic drug hunters

Wednesday, November 6, 2013 03:45 PM

GSK has selected eight winners in its first Discovery Fast Track competition, designed to translate academic research into starting points for new potential medicines. The contest attracted 142 entries across 17 therapeutic areas from 70 universities, academic research institutions, clinics and hospitals in the U.S. and Canada. 

More... »

CRF Health eCOA webinar series

CTCA names Giuseppe Del Priore national director, southeastern regional director

Tuesday, November 5, 2013 11:31 AM

Cancer Treatment Centers of America (CTCA) has announced the appointment of Giuseppe Del Priore, M.D., MPH as the national director of gynecologic oncology. Based out of the CTCA Southeastern Regional Medical Center in Georgia, Del Priore will oversee the organization's national gynecologic oncology practice.

More... »

Alexander Poltorak joins Spherix board of directors

Monday, November 4, 2013 12:54 PM

Spherix, an intellectual property development company committed to the fostering and monetization of intellectual property, has appointed Alexander Poltorak to Spherix's board of directors.

More... »

Richard Segiel, Jr. joins Almac as vice president of U.S. business development

Thursday, October 31, 2013 10:00 AM

Richard Segiel, Jr. has joined Almac’s clinical services business unit as vice president of business development for the U.S. He will focus on developing new business, maintaining existing business and developing partnerships.

More... »

Quintiles named a Best Multinational Workplace for third consecutive year

Thursday, October 31, 2013 09:00 AM

Quintiles has been recognized as one of the World’s Best Multinational Workplaces by Great Place to Work, ranking 18th on the 2013 list. 

More... »

ShangPharma appoints Arthur Taveras president and CSO

Monday, October 28, 2013 12:08 PM

CRO ShangPharma has announced that Dr. Arthur Taveras will join the company as president and chief scientific officer. Taveras brings pharmaceutical leadership and technical experience in drug discovery, chemistry R&D and pharmaceutical development having worked as a pharmaceutical and biotech executive during his 24 year career.

More... »

IDDI simplifies collaboration, switches to Veeva Systems’ Vault eTMF Solution

Wednesday, October 23, 2013 04:31 PM

International Drug Development Institute (IDDI), an international functional CRO headquartered in Belgium, replaced its mix of a paper-based trial master file (TMF) and e-rooms with Veeva Systems’ cloud-based Vault eTMF solution, part of Veeva’s Development Suite. As a CRO that collects, analyses and reports all data from international phase I through IV clinical trials for sponsors throughout the U.S., Europe and Asia, IDDI wanted a single, centralized system to streamline auditing and collaboration. After evaluating five systems, IDDI chose Vault eTMF for its document tracking capabilities and globally accessible cloud platform.

More... »

BioDelivery Sciences appoints Ernest De Paolantonio CFO

Tuesday, October 22, 2013 09:00 AM

BioDelivery Sciences International, a specialty pharmaceutical company, has appointed Ernest R. De Paolantonio chief financial officer and corporate secretary.

More... »

Celladon appoints Michael Narachi chairman of the board

Friday, October 18, 2013 01:15 PM

Celladon, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, has appointed Michael Narachi chairman of the board of directors.

More... »

Immune Pharmaceuticals changes board of directors

Thursday, October 17, 2013 11:01 AM

Immune Pharmaceuticals has announced that Rene Lerer, M.D., executive chairman of Magellan Health Services, and Daniel Kazado, senior advisor to Melini Capital, have joined the company's board of directors. Lerer and Kazado replace Pierre Albouy and Herve de Kergrohen, who have resigned from the board but will continue as strategic advisors to the company.  The board will continue to consist of seven members.

More... »

CenterWatch Drugs in Clinical Trials



Browse by:


April 21

Healthcare IPOs soar in first quarter

Survey compares 'push/pull' tactics in patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs